IBR gains Australian patent for anti-ageing Snowflake ingredient

By Andrew MCDOUGALL contact

- Last updated on GMT

IBR gains Australian patent for anti-ageing Snowflake ingredient
Natural active ingredient supplier IBR has been given a boost in its quest to penetrate the Eastern markets after it was granted a patent for its IBR-Snowflake product in Australia, to go with the one it has already picked up in China.

The patent relates to the use of IBR-Snowflake for promoting skin benefits, with the Israel-based company claiming it smoothes skin, reduces wrinkles and slows down skin ageing.

IBR-Snowflake relies on an aqueous extract from summer snowflake bulbs and is based on the Dormins technology platform that uses natural extracts from plants in their dormant stage to slow down cell proliferation.

The patent relates to these Leucojum extracts, particularly to aqueous extracts of Leucojum bulbs effective in inhibiting contraction of muscle cells or tissues.

Patent

It also covers them as anti-oxidants or compositions that act as a relaxant of cutaneous muscles effective in treating and preventing wrinkles, fine lines and oxidative damages of the skin.

"This patent is an additional support and protection of this excellent active ingredient of ours already shown to be effective as anti-wrinkle ingredient with additional skin benefits of anti-ageing, boost of natural skin defense by enhancing SOD expression as well as lightening and evening the skin tone,”​ says IBR Vice-President of Business Development Dr von Oppen-Bezalel.

It joins the series of patents, applications and trademarks in IBR's portfolio including its Dormins technology and the colourless carotenoids, phytoene and phytofluene.

"The expansion of IBR's patent portfolio promotes our global market growth and strengthen our positioning as a market leader and provider of innovative active ingredients,"​ adds Oppen-Bezalel.

Tried and tested

Trials were initially carried out on the product years ago in France on 21 healthy female volunteers aged between 42 – 64, to test the efficacy of the product.

The trial was double blind placebo controlled with randomized application, and saw one group apply IBR-Snowflake in a 2% concentration in a cream for 28 days.

The analysis of the test results was carried out using Skin Image Analyser and Primos, showing that the 2% dose reduces micro relief furrows by 30% and a 15% decrease in medium depth wrinkles.

Related products

show more

Sensiva™ go natural,a protector without compromise

Sensiva™ go natural,a protector without compromise

Ashland Global Holdings Inc | 24-Jun-2022 | Technical / White Paper

Consumers are increasingly buying natural, organic beauty and wellbeing products as noted from the increasing number of product launches with natural claim...

Formulating for Clean Beauty

Formulating for Clean Beauty

Elementis | 26-May-2022 | Product Brochure

Water scarcity and water pollution continues to be a concern for the environment. Every year, about 130 tons of microplastic particles from personal care...

Caressense™ biofunctional, powering ageless beauty

Caressense™ biofunctional, powering ageless beauty

Ashland Global Holdings Inc | 01-May-2022 | Data Sheet

For the first time, Ashland researchers reveal a natural bioactive that can activate skin’s sensors of touch, the piezos, to release “feel-good” and anti-aging...

Related suppliers

Follow us

Products

View more

Webinars

Indie Pioneers Podcast

Indie Pioneers Podcast